Related Experiment Videos
[Hyperthermic treatment in patients with benign prostatic hypertrophy]
1Department of Urology, Osaka City University Medical School.
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology
|February 1, 1991
Summary
Transrectal hyperthermia effectively improved symptoms and urinary flow in benign prostatic hypertrophy (BPH) patients. This non-invasive treatment reduced residual urine and allowed catheter removal in some patients with urinary retention.
Area of Science:
- Urology
- Oncology
- Medical Physics
Context:
- Benign prostatic hypertrophy (BPH) affects a significant portion of the aging male population.
- Current treatments for BPH include medication, surgery, and minimally invasive procedures.
- Transrectal hyperthermia offers a novel approach to BPH management.
Purpose:
- To evaluate the efficacy and safety of transrectal hyperthermia in treating benign prostatic hypertrophy (BPH).
- To assess changes in subjective symptoms, residual urine volume, uroflowmetry, and prostate volume post-treatment.
Summary:
- Thirty-one patients with BPH underwent transrectal hyperthermia, with prostates heated to 43-45°C over 10 sessions.
- All patients reported improved subjective symptom scores.
- Significant reductions in residual urine volume and improvements in maximum and mean flow rates were observed. Prostate volume remained unchanged. Catheter removal was possible in 4 of 8 patients with urinary retention. No adverse reactions were reported.
Impact:
- Transrectal hyperthermia demonstrates potential as a safe and effective treatment option for BPH.
- This modality may offer a non-invasive alternative for managing lower urinary tract symptoms associated with BPH.
- Further research could explore long-term outcomes and optimal treatment parameters for hyperthermia in BPH.